Thanks to TD Cowen Inc., and Phil Nadeau for hosting Voyager during yesterday's fireside chat as part of the Genetic Medicines & RNA Summit. Hear what Al Sandrock, CEO, and Todd Carter, CSO, shared on the 4 Ps underlying Voyager's progress: robust Pipeline, foundational Platform, key Partnerships, and the Potential of our approach in neurogenetic medicines. The webcast replay can be accessed here: https://bit.ly/4bc8vzK #investors #biotechnology #innovation
Voyager Therapeutics, Inc.’s Post
More Relevant Posts
-
If you missed Eclipsebio’s webinar: Interrogating RNA Structure & Translation Dynamics with SHAPE & Ribosome Profiling, no worries. There’s a recording! Learn about two assays optimized by Eclipsebio to accelerate both academic discoveries and biopharma advancements: eRibo Pro™ (#RiboSeq) to quantitate #ribosome occupancy across a transcript, and eSHAPE™ (#SHAPEMaP) chemical probing to accurately predict #RNA secondary structure. Watch the Webinar - https://lnkd.in/g5deiq38 . . . . #biotech #genomics #proteomics #biotechnology #rnatherapeutics #rnaseq #Ribosomeprofiling #Translatomics
To view or add a comment, sign in
-
-
#PrecisionTherapies are rapidly advancing, targeting #DNA, RNA, proteins, and more to provide multiomic and curative treatments. Our research at ARK Investment Management LLC suggests that the value of companies focused on precision therapies could grow by 28% annually over the next seven years, increasing from around $820 billion in 2023 to approximately $4.5 trillion by 2030. In this video, Brett Winton (our Chief Futurist) explains why this decade will be a game-changer for healthcare and investment opportunities. Capital at Risk. #ARKInvest #ActiveETFs #Genomics #ThematicInvesting
The Potentials of Precision Therapies - ARK Invest Europe
To view or add a comment, sign in
-
The future of genomic data is your use case. NashBio wants to empower you with multi-modal data. Watch a short clip of Judsen Schneider, CTO at NashBio, presenting “The Alliance for Genomic Discovery (AGD) and the Future of Genomics-Powered Research” at #BioTechX Europe earlier this month. Reach out to Seth Belcher, Gemma Hughes, or Judsen Schneider to schedule a time to discuss your clinical RWD plans. #Genomics #Genetics #Biobanking #DrugDevelopment #GenomicMedicine #personalizedmedicine #BioTechX
To view or add a comment, sign in
-
UG People | Shay Stautz, M.S. Shay Stautz serves as UGenome’s Director of Federal Strategy. He has represented two top 100 research universities and numerous research companies in Washington DC, honing their congressional engagement and securing federal research funding. He is a former candidate for US Congress and author of multiple articles on American strategy and research priorities. #ugenome, #ugenomeai, #ugenomebiotech, #bioinformatics, #biotech, #genetics, #science, #dna, #research, #genomics, #medicine, #immunology, #drugdiscovery, #datascience, #lifesciences, #biostatistics, #health, #pharma, #genomeannotation, #pharmacogenomics, #pharmacogenetics, #genomicmedicine, #sequencing, #dataanalysis, #machinelearning, #precisionmedicine, #metagenomics,
To view or add a comment, sign in
-
-
#Mirxes’s Genomics team is thrilled to launch our Price Match Campaign* for next-generation sequencing (NGS) services, which guarantees top-notch NGS services at an unbeatable price. Our Genomics team specializes in white glove genomic services for researchers and biopharma partners, and we are committed to providing quality service from the initial project discussion to the final delivery of results. Find out more at: https://lnkd.in/gp_NS2Wa *This campaign is eligible for territories of Southeast Asia, USA, Japan and Australia only. #preventivehealthcare #precisionmedicine #biotech #researchanddevelopment #earlydetection #earlydetectionsaveslives #healthcare #cancerearlydetection #MirxesGenomics #PriceMatchCampaign #NGS #Genomics #Biotech #NGSSequencing #GenomicsResearch #NextGenSequencing #DNASequencing #GenomeAnalysis #Bioinformatics
To view or add a comment, sign in
-
-
💡 The Genedrive System is a molecular diagnostic device designed for use at the #pointofcare. ⌛ When used with the Genedrive CYP2C19 ID Kit, results are provided in approximately 69 minutes. 👍 The rapid time to results is just ONE reason why NICE recommended our #CYP2C19 test (used with the Genedrive System) in recent draft guidance. 🔗 Read the full press release: https://lnkd.in/ehRYxMfT #GDR #pharmacogenetics #pharmacogenomics #diagnostics #medtech #healthtech #genetics #POCT
To view or add a comment, sign in
-
-
Life Edit Therapeutics nuclease collection features a range of protospacer adjacent motifs (PAMs), which facilitates the targeting of genetic mutations in tighter windows and provides broad genome access. Learn more about how we partner around our platform technologies at elevate.bio/partnering. #Biotechnology #PAMS #InnovateAtElevate
To view or add a comment, sign in
-
-
🌟 Join CREAPHARM during 2 two major events, early April -#biomanufacturing #CellandGene 🎯 [Congrès France Bioproduction – 8ème édition] 📅 April 3 & 4 📍 Paris #CFB24, a POLEPHARMA must-attend event where you will have the opportunity to meet Mohamed SIDI YKHLEF, Nathan Bendaoud, Frédéric Malboze, Eric Placet and Carla Da Costa. Start designing the right solution for your #UltraCold storage needs, your disaster plan or the set-up of a highly-reliable supply chain for your experimental or commercial #ATMP. 👉 Don't miss the workshop "#Biomedicines Supply Chain: Challenges & Technological Solutions" on April 3rd, 11.45 am Get expert content during this session co-animated by Frédéric Malboze, Expert in #Cryopreservation and General Manager of the CREAPHARM's site dedicated to ultra-cold and ATMP supply chain, and Benoit Pinteur, CSO at Brenus Pharma, sharing experiences on this partnership. 🎯 [Cell & Gene Meeting on the Med] 📅 April 9 & 11 📍 Rome Looking for a highly-skilled team to deal with your challenges in the supply chain management of your cell and gene therapy products? 👉 Arrange a B2B meeting with Nathan Bendaoud and kickstart the design of reliable solutions, tailored to your needs. See you there! #Biotech #SupplyChain #biobanking #biorepository #LN2 #clinicaltrials
To view or add a comment, sign in
-
-
Business Development manager for Biodevelopment Services South of Europe and Israel-Merck Life Science
The Aptegra™ CHO genetic stability assay is a faster, high resolution, all-in-one solution to replace up to five different methods previously required for genetic stability determination of recombinant CHO clonal cell lines generated using single insertion vectors. Want to learn more? Join us at ESACT and meet Pamela Hamill for her insightful poster presentation!
To view or add a comment, sign in
-
NEW | Obtain maximum knockdown efficiency and low cell toxicity in eukaryotic cells with #FuGENE® SI, our newest and only small-#RNA #transfection reagent. Request a free sample today: https://bit.ly/46889HQ Learn more about the latest versatile transfection reagent for siRNA, miRNA and other small RNA molecules here: https://bit.ly/461qR3T #Promega #lifescience #biotechnology
FuGENE® SI Transfection Reagent
promega.com
To view or add a comment, sign in
Director Client Services at Hobson Prior
4dVery interesting, thanks for sharing